The demand for Heart Pump Devices is primarily attributed to factors such as the rising prevalence of cardiovascular diseases, increased time duration pertaining to heart transplants, and the entrance of key companies such as Abbott Laboratories, Abiomed, Inc., Teleflex Incorporated, SynCardia Systems, LLC, St. Jude Medical Inc., and others in the market. These all factors are directly related to the growth of the Heart Pump Devices market.
LAS VEGAS, July 20, 2022 /PRNewswire/ -- DelveInsight's Heart Pump Devices Market Insights and Forecast report provides the current and forecast Heart Pump Devices Market, upcoming innovations in the devices, individual market shares, challenges, drivers and barriers, market trends, and key competitors in the Heart Pump Devices Market.
Some of the essential takeaways from the Heart Pump Devices Market report:
- As per DelveInsight analysis, in terms of revenue share, North America is predicted to register the fastest growth in the Heart Pump Devices market.
- Some of the Global Heart Pump Devices Device companies with access devices in various stages of development include Abbott Laboratories, Abiomed, Inc., Teleflex Incorporated, SynCardia Systems, LLC, St. Jude Medical Inc. CARMAT, CorWave SA, Medtronic Inc., Terumo Heart, Inc., Calon Cardio-Technology Ltd., NovaPump GmbH, Fresenius Medical Care AG & Co. KGaA, Angiodroid srl, Getinge AB, and others.
- DelveInsight analysis states that the Global Heart Pump Devices Market was valued at USD 2.73 Billion in 2021, growing at a CAGR of 15.16% during the forecast period from 2021 to 2027 to reach USD 6.35 Billion by 2027.
- In August 2021, the United States FDA granted breakthrough device designation to Abiomed's Impella ECP expandable percutaneous Heart Pump. The designation means the FDA will prioritize Impella ECP's regulatory review processes, including design iterations, clinical study protocols, and pre-market approval (PMA) application.
- On June 30, 2021, Abiomed's heart pump Impella RP with SmartAssist technology received the United States FDA pre-market approval.
- In February 2021, CARMAT received FDA approval to conduct an Early Feasibility Study (EFS) of its Total Artificial Heart in the US using BlueSync technology.
- In December 2020, Abbott received FDA approval for the updated labeling for the HeartMate 3 Heart Pump to be used in pediatric patients with advanced refractory left ventricular heart failure.
- On February 04, 2020, Abbott received the Food and Drug Administration's Breakthrough device designation for its Fully Implantable Left Ventricular Assist System (FILVAS), currently under the process of development.
- On February 11, 2019, Leviticus Cardio and Jarvik Heart unveiled the use of the first FIVAD device for wireless power implanted in humans in Kazakhstan. The device uses coplanar energy transfer for wirelessly providing power to the heart pump, also known as the Ventricular Assist Device (VAD). Thus, owing to such development as product launches, there will be significant growth observed in the Heart Pump Devices market during the forecast period.
To pick on the latest highlights related to the Heart Pump Devices implantable device market, get a snapshot of the key highlights entailed in the Heart Pump Devices Market Sample Report
Heart Pump Devices Overview
Heart failure is a condition wherein the heart is not able to pump an adequate amount of blood to meet the requirements of the body. The cause of heart failure depends on several factors such as pre-myocardial infarction (heart attack), high blood pressure, heart diseases, atrial fibrillation, and others such as a coronary artery. In order to help cardiac circulation, several types of cardiovascular pumping systems are available in the market. The devices are surgically implanted and used in humans suffering from low heart.
Heart Pump Devices Market Insight
Geographically, the Global Heart Pump Devices market is studied for North America, Europe, Asia-Pacific, and the Rest of the World. Regarding revenue, North America accounts for the highest revenue share compared with the Global Heart Pump Devices market, which will remain constant during the forecast period. However, the domination of North America will be conspicuously challenged by the European market. This domination is attributed to the increased cardiovascular disease prevalence in the region, the rising number of regulatory approvals, and the favorable refund scheme.
Various Heart Pump Devices market growth opportunities can also be witnessed for other countries, including European countries owing to the rising number of patients suffering from cardiovascular disease and the recent launch of new products in this region.
Moreover, the regional companies are increasing their manufacturing of essential medical device products. For instance, in August 2021, the United States Food and Drug Administration (FDA) has granted breakthrough device designation to Abiomed's Impella ECP expandable percutaneous Heart Pump. The designation means the FDA will prioritize Impella ECP's regulatory review processes including design iterations, clinical study protocols, and pre-market approval (PMA) application.
Click here to understand more about the key players in the Heart Pump Devices Market and their future @ Heart Pump Devices Future Assessment
Heart Pump Devices Market Dynamics
The major factors driving the demand for Heart Pump Devices are the increasing prevalence of cardiovascular diseases, the rising geriatric population, technology advances, new product development by the Heart Pump Devices market players. Heart Pump devices were found to be extremely beneficial in heart failure cases in COVID-19, which further pushed the demand for these devices during the pandemic situation. Due to a scarcity of heart suppliers, cardiac pumps are an optimal solution that encourages Global market expansion.
On the contrary, factors such as the high cost of the pump and a low repayment scenario in developing countries are nevertheless projected to inhibit the growth of the Heart Pump Devices market. COVID-19 pandemic has been observed to be an incomparable public health emergency that has affected almost every industry, and its long-term effects of it are projected to impact the healthcare market. As for the Heart Pump Devices market, they had observed a period of slow growth because of heart pump device stock-outs, unavailability of the heart pump devices, and closed clinics.
However, the manufacturing companies and clinics are slowly resuming their operations. Patient visits are also gradually increasing after the relaxation given as per the new lockdown guidelines. There is still an increasing amount of research going on regarding the use of Heart Pump Devices in COVID-19 patients. Hence, the devices are slowly gaining normalcy regarding Heart Pump Devices market growth.
To gain a better understanding of the COVID-19 impact on Heart Pump Devices, get a snapshot of the COVID-19 Impact on the Heart Pump Devices Market
Scope of the Heart Pump Devices Market Report
- Coverage: Global
- Study Period: 2019-2027
- Market Segmentation By Product - Ventricular Assist Devices- Left Ventricular Assist Devices (LVAD), Percutaneous Ventricular Assist Devices (PVAD), Biventricular Ventricular Assist Devices (BIVAD), Right Ventricular Assist Devices (RVAD), and Intra-Aortic Balloon Pumps, Total Artificial Hearts
- Market Segmentation By Type - Implanted Heart Pump Device, Extracorporeal Heart Pump Device
- Market Segmentation By Therapy - Bridge-To-Transplant (BTT), Bridge-To-Candidacy (BTC), Destination Therapy (DT)
- Market Segmentation By End-User - Hospitals, Cardiac Centres, Ambulatory Surgical Centres
- Market Segmentation By Geography - North America, Europe, Asia-Pacific, and Rest of the World
- Key Heart Pump Devices Companies - Abbott Laboratories, Abiomed, Inc., Teleflex Incorporated, SynCardia Systems, LLC, St. Jude Medical Inc. CARMAT, CorWave SA, Medtronic Inc., Terumo Heart, Inc., Calon Cardio-Technology Ltd., NovaPump GmbH, Fresenius Medical Care AG & Co. KGaA, Angiodroid srl, Getinge AB and others.
- Product Profiles, Case Studies, KOL's Views, Analyst's View
Delveinsight Analysis: The Global Heart Pump Devices Market size was valued atUSD 2.73 Billion in 2021, growing at a CAGR of 15.16% during the forecast period from 2022 to 2027, to reach USD 6.35 Billion by 2027.
Know more about which MedTech player is set to emerge as the trendsetter in the Global Heart Pump Devices Market @ Key Heart Pump Devices Companies Analysis
Table of Contents
1 | Heart Pump Devices Market Report Introduction |
2 | Heart Pump Devices Market Executive summary |
3 | Heart Pump Devices Market Regulatory and Patent Analysis |
4 | Heart Pump Devices Market Key Factors Analysis |
5 | Heart Pump Devices Porter's Five Forces Analysis |
6 | COVID-19 Impact Analysis on Heart Pump Devices Market |
7 | Heart Pump Devices Market Layout |
8 | Heart Pump Devices Market Global Company Share Analysis - Key 3-5 Companies |
9 | Heart Pump Devices Market Company and Product Profiles |
10 | Project Approach |
11 | KOL Views |
12 | DelveInsight Capabilities |
13 | Disclaimer |
14 | About DelveInsight |
Learn more about the Heart Pump Devices@ Heart Pump Devices Regulatory Landscape
Related Reports
Cardiac Valvulotome Market
"DelveInsight's 'Cardiac Valvulotome Market Insight, Competitive Landscape and Market Forecast, 2027' report delivers an in-depth understanding of Cardiac Valvulotome and the historical and forecasted Cardiac Valvulotome market trends, globally, which comprises of North America, Europe, APAC, and RoW, market drivers & barriers, unmet needs, and key companies involved such as Braun Melsungen AG, LeMaitre Vascular, Inc., Andramed GmbH,BD., InvaMed, Koven Technology Canada Inc, and others.
Cardiac Resynchronization Therapy Market
"DelveInsight's 'Cardiac Resynchronization Therapy Market Insight, Competitive Landscape and Market Forecast, 2027' report delivers an in-depth understanding of Cardiac Resynchronization Therapy and the historical and forecasted Cardiac Resynchronization Therapy market trends, globally, which comprises of North America, Europe, APAC, and RoW, market drivers & barriers, unmet needs, and key companies involved such as Boston Scientific Corporation, Medtronic, Medico S.p. A, Microport Scientific Corporation, Biotronik, EBR Systems, Abbott, and others.
Cardiac Restoration Systems Market
"DelveInsight's 'Cardiac Restoration Systems Market Insight, Competitive Landscape and Market Forecast, 2027' report delivers an in-depth understanding of Cardiac Restoration Systems and the historical and forecasted Cardiac Restoration Systems market trends, globally, which comprises of North America, Europe, APAC, and RoW, market drivers & barriers, unmet needs, and key companies involved such as Abbott, BioVentrix, CryoLife, Edwards Lifesciences Corporation,NeoChord, XELTIS, and others.
Cardiac Output Monitors Market
"DelveInsight's 'Cardiac Output Monitors Market Insight, Competitive Landscape and Market Forecast, 2027' report delivers an in-depth understanding of Cardiac Output Monitors and the historical and forecasted Cardiac Output Monitors market trends, globally, which comprises of North America, Europe, APAC, and RoW, market drivers & barriers, unmet needs, and key companies involved such as Osypka Medical GmbH, CNSystems Medizintechnik GmbH., Uscom,Deltex Medical Limited, Edward Lifesciences Corporation, ICU Medical, Inc., LiDCO, Baxter., Getinge AB., GE Healthcare (GENERAL ELECTRIC COMPANY), Biotronik, and others.
Cardiac Monitoring Devices Market
Global Cardiac Monitoring Devices Market report delivers an in-depth understanding of Cardiac Monitoring Devices and the historical and forecasted Cardiac Monitoring Devices market trends, market drivers & barriers, unmet needs, and key companies involved such as Medtronic, Boston Scientific, Abbott Laboratories, GE Healthcare, BIOTRONIK, and Koninklijke Philips, Asahi Kasei Corporation, MicroPort Scientific Corporation, Hill-Rom Holdings, Nihon Kohden, SCHILLER AG, BioTelemetry, BPL Medical Technologies, ACS Diagnostics, and others.
Cardiac Biomarkers Testing Market
Global Cardiac Biomarkers Testing Market report delivers an in-depth understanding of Global Cardiac Biomarkers Testing market trends, market drivers & barriers, unmet needs, and key companies involved such as Beckman Coulter, Siemens Healthcare GmbH, Abbott, bioMérieux SA, F. Hoffmann-La Roche Ltd, Thermo Fischer Scientific Inc, Randox Laboratories Ltd, Tosoh Corporation, DIALAB GmbH, CardioGenics Holdings Inc, and others.
Cardiac Assist Devices Market
Global Cardiac Assist Devices Market report delivers an in-depth understanding of Global Cardiac Assist Devices and the historical and forecasted Global Cardiac Assist Devices market trends, market drivers & barriers, unmet needs, and key companies involved such as Abbott Laboratories, Teleflex Incorporated, SynCardia Systems, LLC, St. Jude Medical Inc, CARMAT, CorWave SA, Medtronic PLC, Terumo Heart, NovaPump GmbH, Getinge AB Balton Ltd, Meril Life Sciences Pvt. Ltd, Thoratec Corporation, and others.
3D Cardiac Mapping System Market
"DelveInsight's '3D Cardiac Mapping System - Market Insight, Competitive Landscape and Market Forecast, 2027' report delivers an in-depth understanding of 3D Cardiac Mapping System and the historical and forecasted 3D Cardiac Mapping System market trends, globally, which comprises of North America, Europe, APAC, and RoW, market drivers & barriers, unmet needs, and key companies involved such as Biosense Webster, (Jhonson & Jhonson), Boston Scientific Corporation, Abbott, Kardium, Medtronic, Catheter Robotics, Inc, Lepu Medical, EP Solutions SA, and others.
Browse Through Our Blog Posts
- Rising Global Prevalence of Cardiovascular Diseases And Top Players In Cardiology
- With advancements in Innovative Technology, Cardiac Monitoring Devices Market is Booming Significantly
- Mapping the Increasing Burden of Heart Failure: What Does it Bring for Healthcare Market Companies?
- What Factors are Shaping the Trends in the Implantable Cardiac Monitors Market?
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Connect With Us at LinkedIn | Facebook | Twitter
Contact Us
Shruti Thakur
info@delveinsight.com
+1(919)321-6187
www.delveinsight.com
Logo: https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg
